1. Home
  2. RNW vs NVAX Comparison

RNW vs NVAX Comparison

Compare RNW & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$5.50

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.82

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
NVAX
Founded
2011
1987
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
RNW
NVAX
Price
$5.50
$6.82
Analyst Decision
Buy
Hold
Analyst Count
2
8
Target Price
$7.25
$9.75
AVG Volume (30 Days)
2.0M
3.2M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
413.66
N/A
EPS
0.26
2.07
Revenue
$1,382,164,625.00
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
$17.07
N/A
P/E Ratio
$21.03
$3.35
Revenue Growth
46.76
20.27
52 Week Low
$5.05
$5.01
52 Week High
$8.24
$11.55

Technical Indicators

Market Signals
Indicator
RNW
NVAX
Relative Strength Index (RSI) 24.25 47.95
Support Level $5.05 $6.36
Resistance Level $5.69 $7.00
Average True Range (ATR) 0.20 0.22
MACD -0.12 0.07
Stochastic Oscillator 17.54 66.67

Price Performance

Historical Comparison
RNW
NVAX

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: